Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications

E Angelopoulou, ES Pyrgelis, C Piperi - Neurochemistry international, 2020 - Elsevier
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with
current treatment being mainly symptomatic and often accompanied by serious side effects …

Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications.

E Angelopoulou, ES Pyrgelis, C Piperi - Neurochemistry …, 2019 - europepmc.org
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with
current treatment being mainly symptomatic and often accompanied by serious side effects …

Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications

E Angelopoulou, ES Pyrgelis… - Neurochemistry …, 2020 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with
current treatment being mainly symptomatic and often accompanied by serious side effects …

Neuroprotective potential of chrysin in Parkinson's disease: molecular mechanisms and clinical implications.

E Angelopoulou, ES Pyrgelis, C Piperi - 2020 - cabidigitallibrary.org
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with
current treatment being mainly symptomatic and often accompanied by serious side effects …